Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic

IMPORTANCE: The COVID-19 pandemic disrupted medical care, impacting prescribing of opioid analgesics and buprenorphine for opioid use disorder. Understanding these patterns can help address barriers to care. OBJECTIVE: To evaluate how prescribing of opioid analgesics and buprenorphine for opioid use...

Descripción completa

Detalles Bibliográficos
Autores principales: Currie, Janet M., Schnell, Molly K., Schwandt, Hannes, Zhang, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050741/
https://www.ncbi.nlm.nih.gov/pubmed/33856474
http://dx.doi.org/10.1001/jamanetworkopen.2021.6147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050741/
https://www.ncbi.nlm.nih.gov/pubmed/33856474
http://dx.doi.org/10.1001/jamanetworkopen.2021.6147

Ejemplares similares